Monitor the next proxy statement for the board slate and any potential governance changes. The departure of a director at a micro-cap with a $5M market cap is routine and unlikely to move the stock.
Price Chart
Executive Summary
Director Dr. Andrew Keller notified Sunshine Biopharma that he will not seek reelection upon expiration of his current term at the next annual shareholder meeting. This is a routine board departure with no immediate operational impact, though it reduces board continuity at a micro-cap pharmaceutical company.
Key Facts
- Director Dr. Andrew Keller will not seek reelection to the board.
- His current term expires at the next annual shareholder meeting.
- No replacement has been named, and no reason for the departure was given beyond not seeking reelection.
- The filing is a routine Item 5.02 disclosure with no financial data or material agreements.
Financial Impact
No financial impact disclosed.
Risk Factors
- Reduced board continuity at a micro-cap company.
- Potential difficulty attracting qualified directors given the small market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-006777 |
| Document: 0001683168-26-006777-index.html | 0001683168-26-006777 |
| Document: 0001683168-26-006777.txt | 0001683168-26-006777 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | SC 13G | $0.2430 $0.2154 | ▼ −11.36% | ▼ −11.81% | $2.96 (+1118.11%) |
Oct 13, 2026 14d ago | SC 13G | $0.2430 $0.2154 | ▼ −11.36% | ▼ −11.81% | $2.96 (+1118.11%) |
Oct 9, 2026 18d ago | 8-K | $0.3020 $0.2418 | ▲ +19.93% | ▲ +18.44% | $2.96 (−880.13%) |
Oct 9, 2026 18d ago | 424B4 | $0.3020 $0.2418 | ▲ +19.93% | ▲ +18.44% | $2.96 (−880.13%) |
Oct 8, 2026 20d ago | EFFECT | $0.4300 $0.2300 | ▲ +46.51% | ▲ +46.24% | $2.96 (−588.37%) |
Oct 5, 2026 22d ago | SC 13G/A | $0.3979 $0.2363 | ▲ +40.61% | ▲ +40.47% | $2.96 (−643.91%) |
Oct 2, 2026 25d ago | S-1 | $0.4201 $0.3020 | ▲ +28.11% | ▲ +28.53% | $2.96 (−604.59%) |
Sep 9, 2026 7w ago | EFFECT | $1.12 $1.04 | ▲ +7.59% | ▲ +7.26% | $2.96 (−164.29%) |
Aug 28, 2026 8w ago | 8-K | $1.12 $1.15 | ▲ +2.68% | ▲ +2.82% | $2.96 (+164.29%) |
Aug 3, 2026 12w ago | 8-K | $23.40 $24.40 | ▲ +4.27% | ▲ +2.25% | $2.96 (−87.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers